MAJOR REBOUND UNDERWAY !!!!!!!

Discussion in 'Acorda Therapeutics' started by anonymous, Nov 1, 2019 at 4:28 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    by your post can tell you have no faith in management. Too bad, as we have a strong leadership corps that will direct us into recovery. jus be patient ...with many years in this biz I know that ther are ups an downs and must role with the punches !
     

  2. anonymous

    anonymous Guest

    Habib, you are the ONLY person who believes Ron and his band of sycophants have what it takes, and you are paid to think that.
     
  3. anonymous

    anonymous Guest

    ron and habib will lead us to the promised land.
     
  4. anonymous

    anonymous Guest

    And that promise land is a hole in the ground.
     
  5. anonymous

    anonymous Guest


    Many are fans of the Leadership Team. Many feel obligated to post on CP to defend them. We have a tremendous team at HQ, and we al know it !
     
  6. anonymous

    anonymous Guest

    HQ team does not directly drive sales. Sales team does and they were slashed
     
  7. anonymous

    anonymous Guest

    Yes the sales Team is critical to our sucess! The front line is our 'face' to the health professionals. All the more reason to git out there and praise our Company and the Leaders at HQ ! We do NOT need and attacks Here on CP. The world is viewing this ! We are WORLD CLASS management and sales !!
     
  8. anonymous

    anonymous Guest

    Only you Habib. That’s what they pay you for.
     
  9. anonymous

    anonymous Guest

    Habib is leading the charge.
     
  10. anonymous

    anonymous Guest

    Not attacks... just stating reality and fact. Your. $0.60 away from $1.00 share price. Better get moving and change before you drop anymore. Your running out of runway to prove your worth. Stop posting on here and got out there and make the change....
     
  11. anonymous

    anonymous Guest

    Greetings from the front line.......sometimes the truth hurts. Our fearless leaders have really let us down! Stop passing the blame on the field. We have done what we were told to do, which by the way seems to change weekly.....
     
  12. anonymous

    anonymous Guest

    Greetings from the front line.......sometimes the truth hurts. Our fearless leaders have really let us down! Stop passing the blame on the field. We have done what we were told to do, which by the way seems to change weekly.....
     
  13. anonymous

    anonymous Guest

    THE BOD NEEDED TO FIRE LS AND RC A LONG TIME AGO.
     
  14. anonymous

    anonymous Guest

    The BOD is judiciously monitoring the performance of ALL in Leadership. They will NOT act irresponsibly without measuring all the facts,which may take more time than some would like. Yes the BOD is doing a fine job. Rest assured they will act as required to maximize shareholder value. We are fortunate to have WORLD CLASS BOD members who are not afraid to act decisively ! !
     
  15. anonymous

    anonymous Guest

    The fact is your leadership has lost 97% of its market cap. What other facts do you need. If a rep was down 97% in sales performance they would be gone. Your leader has De-maximized shareholder value. Penny stock before new year.
     
  16. anonymous

    anonymous Guest

    The BOD may appear to act slow but is no doubt deliberating the options available to energize the rebound. No doubt share price decline is a factor of concern, but evidently not the top of the list. Acorda must improve its international marketing / PR strategy of Inbrija, correct the FDA filing safus that hurt its roll out, stabilize the field team, and then cleanup the C-suite. This list is from an outside opinion.
     
  17. anonymous

    anonymous Guest

    Habib, the BOD doesn’t appear to be moving slow, they appear to be asleep at the wheel.

    When leadership has eroded over 95% of value, something needs to change. This isn’t a bad quarter, this is ongoing over the past few years.

    Since ACOR has no international presence, they would have been better off licensing ex US rights to Inbrija.

    FDA filing issues only delayed the inevitable. There is a small niche for Inbrija and payers aren’t going to cover it unless they have to. As you are learning, this will cost you 60% in rebates. This makes it a hassle to prescribe and no doctor isn’t going to fight that hard for an alternate delivery of an old drug.

    RC didn’t want to hear it and LS wasn’t going to tell him. Now you live with those decisions.

    Banner day yesterday. Let’s hope you keep it above $1.50 today.
     
  18. anonymous

    anonymous Guest



    All excellent points. We feel your pain. However we have to work with the BOD we have and expect that they will reconstitute the C-Suite at some point. Believe they see the other issues as more urgent thus the inaction re C-Suite. Also there is hope for a big rebound as expressed effectively here on CP. The international and yes domestic market has not even been touched and Inbrija they believe has a huge market.

    Rank & File displeasure as expressed on CP is very deceptive. Most in field are very happy with our current pipeline rollout and are eager to step up. Note a survey of other CP sites revealed a 73% negative post rate. Here at Acorda we are only about40% negative!
     
  19. anonymous

    anonymous Guest

     
  20. anonymous

    anonymous Guest

    Actually share price is top and probably the ONLY thing on the list. It’s their only option to address the debt. Otherwise we are penniless.